Cargando…
Proton pump inhibitors and the risk of Alzheimer’s disease and non-Alzheimer’s dementias
Proton pump inhibitors (PPIs) are among the most prescribed medications. Previous epidemiological studies have presented contradictory results about PPIs and the risk of dementia. Our objective was to investigate the association between the use of PPIs and an increasing risk of incident AD or non-AD...
Autores principales: | Torres-Bondia, Francisco, Dakterzada, Farida, Galván, Leonardo, Buti, Miquel, Besanson, Gaston, Gill, Eric, Buil, Roman, de Batlle, Jordi, Piñol-Ripoll, Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713356/ https://www.ncbi.nlm.nih.gov/pubmed/33273636 http://dx.doi.org/10.1038/s41598-020-78199-0 |
Ejemplares similares
-
Benzodiazepine and Z-Drug Use and the Risk of Developing Dementia
por: Torres-Bondia, Francisco, et al.
Publicado: (2021) -
Evolution of the consumption trend of proton pump inhibitors in the Lleida Health Region between 2002 and 2015
por: Torres-Bondia, F., et al.
Publicado: (2022) -
Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease
por: Dakterzada, Farida, et al.
Publicado: (2023) -
Trends in the consumption rates of benzodiazepines and benzodiazepine-related drugs in the health region of Lleida from 2002 to 2015
por: Torres-Bondia, F., et al.
Publicado: (2020) -
Clinical impact of microbleeds in patients with Alzheimer’s disease
por: Vázquez-Justes, Daniel, et al.
Publicado: (2022)